VIOLIN: Vaccine Investigation and Online Information Network

Vaccine Detail

ALVAC-BTV-CP(VP2/VP5)

Vaccine Information

Vaccine Name: ALVAC-BTV-CP(VP2/VP5)
Target Pathogen: Bluetongue virus
Target Disease: Bluetongue disesase
Vaccine Ontology ID: VO_0004732
Type: Recombinant vector vaccine
Status: Research
Host Species for Licensed Use: Baboon
Vector:
- Vector name:
- VO vector ID: VO_0001128
Preparation: (Boone et al., 2007) recombinant canarypox virus vector (BTV-CP) co-expressing synthetic genes encoding the two outer capsid proteins (VP2 and VP5) of BTV serotype 17
Immunization Route: Intramuscular injection (i.m.)

Host Response

References

Boone et al., 2007: Boone JD, Balasuriya UB, Karaca K, Audonnet JC, Yao J, He L, Nordgren R, Monaco F, Savini G, Gardner IA, Maclachlan NJ. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep. Vaccine. 2007; 25(4); 672-678. [PubMed: 17059856].